XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Operating activities:    
Net earnings $ 68,752,000 $ 80,211,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of property, plant and equipment 33,374,000 31,929,000
Amortization of intangibles and deferred costs 2,586,000 2,639,000
Share-based compensation 3,006,000 2,874,000
Deferred income taxes 690,000 (12,502,000)
Loss on marketable securities 410,000 32,000
Other 350,000 (3,000)
Changes in assets and liabilities net of effects from purchase of companies    
Increase in accounts receivable (14,289,000) (7,530,000)
Increase in inventories (6,257,000) (13,020,000)
Decrease (increase) in prepaid expenses 957,000 (2,949,000)
Increase in accounts payable and accrued liabilities 11,584,000 3,606,000
Net cash provided by operating activities 101,163,000 85,287,000
Investing activities:    
Payment for purchases of companies, net of cash acquired (1,155,000) 0
Purchases of property, plant and equipment (42,136,000) (43,344,000)
Purchases of marketable securities (24,056,000) (65,227,000)
Proceeds from redemption and sales of marketable securities 29,721,000 51,417,000
Proceeds from disposal of property, plant and equipment 1,463,000 1,895,000
Other (212,000) 171,000
Net cash used in investing activities (36,375,000) (55,088,000)
Financing activities:    
Payments to repurchase common stock 0 (2,794,000)
Proceeds from issuance of stock 7,426,000 5,561,000
Payments on capitalized lease obligations (33,000) (278,000)
Payment of cash dividend (27,230,000) (24,652,000)
Net cash used in financing activities (19,837,000) (22,163,000)
Effect of exchange rate on cash and cash equivalents (333,000) (3,370,000)
Net increase in cash and cash equivalents 44,618,000 4,666,000
Cash and cash equivalents at beginning of period 111,479,000 90,962,000
Cash and cash equivalents at end of period $ 156,097,000 $ 95,628,000